Literature DB >> 6638684

The health effects of involuntary smoking.

S T Weiss, I B Tager, M Schenker, F E Speizer.   

Abstract

Involuntary smoking is defined as the exposure of nonsmokers to tobacco combustion products in the indoor environment. Involuntary smokers are exposed to a quantitatively smaller and qualitatively different smoke exposure than active smokers. Quantitation of exposure is particularly difficult in both physiologic and epidemiologic studies. Acute physiologic studies have documented minimal physiologic changes in healthy subjects. However, individuals with heart or lung disease may be differentially affected. A relatively large body of data relates parental (particularly maternal) cigarette smoking to the occurrence of both acute respiratory illnesses and chronic respiratory symptoms in children. The effect seems to be greatest early in life and cannot be separated from in utero exposure. Data linking parental smoking to lower levels of pulmonary function are all cross-sectional and less conclusive. What is apparent is that the magnitude of the direct effect of passive smoke exposure is likely to be relatively small (from 1 to 5% reduction in maximally obtained lung function level in exposed children). Data on adults are insufficient to allow for a quantitative estimate. The important effects of passive smoke exposure in childhood are twofold. The slight reduction in pulmonary function level may predispose individuals to increased risks from environmental agents later in life. In addition, having a parent who smokes substantially increases the likelihood that a child will become a smoker. Finally, two studies have linked lung cancer in nonsmokers to exposure to spouses' cigarette smoke. Further research is needed to confirm these findings. Involuntary smoking may have important health effects, either direct or indirect, which deserve further study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6638684     DOI: 10.1164/arrd.1983.128.5.933

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  A new method to evaluate nicotine exposure in infants.

Authors:  Werner Sauseng; Heinz Zotter; Sigrid Thaller; Reingard Aigner; Reinhold Kerbl
Journal:  Eur J Pediatr       Date:  2004-12-21       Impact factor: 3.183

2.  Prevention of acute respiratory infections.

Authors:  S Singhi; P Singhi
Journal:  Indian J Pediatr       Date:  1987 Mar-Apr       Impact factor: 1.967

3.  Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren.

Authors:  M J Jarvis; M A Russell; C Feyerabend; J R Eiser; M Morgan; P Gammage; E M Gray
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

Review 4.  Primary prevention of allergy and asthma is possible.

Authors:  Allan B Becker
Journal:  Clin Rev Allergy Immunol       Date:  2005-02       Impact factor: 8.667

5.  Bronchiolitis and asthma: are they related?

Authors:  L I Landau
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

6.  Breast feeding and smoking hygiene: major influences on cotinine in urine of smokers' infants.

Authors:  A Woodward; N Grgurinovich; P Ryan
Journal:  J Epidemiol Community Health       Date:  1986-12       Impact factor: 3.710

7.  Respiratory nicotine absorption in non-smoking females during passive smoking.

Authors:  A Iwase; M Aiba; S Kira
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

8.  Relation of passive smoking as assessed by salivary cotinine concentration and questionnaire to spirometric indices in children.

Authors:  D G Cook; P H Whincup; O Papacosta; D P Strachan; M J Jarvis; A Bryant
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

9.  Effects of passive smoking on the pulmonary function of adults.

Authors:  M R Masjedi; H Kazemi; D C Johnson
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

10.  The effect of passive smoking on children's pulmonary function in Shanghai.

Authors:  Y Chen; W X Li
Journal:  Am J Public Health       Date:  1986-05       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.